Farmacología y Toxicología
Departamento
MARÍA JOSÉ
PARELLADA REDONDO
Profesora titular de universidad
Publicaciones en las que colabora con MARÍA JOSÉ PARELLADA REDONDO (23)
2023
-
Analysis of common genetic variation across targets of microRNAs dysregulated both in ASD and epilepsy reveals negative correlation
Frontiers in Genetics, Vol. 14
-
Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up
International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807
-
Oxytocin Exposure in Labor and its Relationship with Cognitive Impairment and the Genetic Architecture of Autism
Journal of Autism and Developmental Disorders, Vol. 53, Núm. 1, pp. 66-79
-
Recent natural selection conferred protection against schizophrenia by non-antagonistic pleiotropy
Scientific Reports, Vol. 13, Núm. 1
2022
-
Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
Schizophrenia, Vol. 8, Núm. 1
-
Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia
Nature Communications, Vol. 13, Núm. 1
-
The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance
The international journal of neuropsychopharmacology, Vol. 25, Núm. 8, pp. 666-677
-
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
European Neuropsychopharmacology, Vol. 57, pp. 105-117
2021
-
A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood
Translational Psychiatry, Vol. 11, Núm. 1
-
A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders
European Neuropsychopharmacology, Vol. 48, pp. 49-88
2019
-
Differences in the regulation of inflammatory pathways in adolescent- and adult-onset first-episode psychosis
European Child and Adolescent Psychiatry, Vol. 28, Núm. 10, pp. 1395-1405
2018
-
Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis
International Journal of Neuropsychopharmacology, Vol. 21, Núm. 5, pp. 410-422
2016
-
BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year
Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151
-
Cognition and psychopathology in first-episode psychosis: Are they related to inflammation?
Psychological Medicine, Vol. 46, Núm. 10, pp. 2133-2144
-
Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis
Journal of Psychiatric Research, Vol. 75, pp. 14-21
2015
-
Inflammation in schizophrenia: A question of balance
Neuroscience and Biobehavioral Reviews, Vol. 55, pp. 612-626
-
Pro-/antiinflammatory dysregulation in early psychosis: Results from a 1-year follow-Up study
International Journal of Neuropsychopharmacology, Vol. 18, Núm. 2, pp. 1-10
2014
-
Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study
Schizophrenia Research, Vol. 156, Núm. 1, pp. 23-29
-
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia
Schizophrenia Bulletin, Vol. 40, Núm. 2, pp. 376-387
2013
-
Peripheral endocannabinoid system dysregulation in first-episode psychosis
Neuropsychopharmacology, Vol. 38, Núm. 13, pp. 2568-2577